Medical research

Musk’s Neuralink submits brain implant patient data to journal

The company aims to implant its chips in 20,000 people per year by 2031, and generate at least US$1 billion in annual revenue

There is currently no effective treatment for paralysis caused by serious spinal cord injuries, which affect more than 150,000 patients in Japan alone, with 5,000 new cases each year.

Stem cell treatment helped improve spinal cord injuries: Japan scientists

[TOKYO] A stem cell treatment helped improve the motor function of two out of four patients with a spinal cord injury in the first clinical study of its kind, Japanese scientists said.

Singapore’s strengths position it to ride the precision-medicine wave. The country has deep research and development and clinical expertise, strengths in genomics, and a burgeoning biomedical industry.

Singapore has a chance to shine in precision medicine

Existing research capabilities and support for new startups can drive growth in this field

Neuralink’s device has a chip that processes and transmits neural signals that could be transmitted to devices such as a computer or a phone.

Elon Musk’s Neuralink gets FDA’s breakthrough device tag for ‘Blindsight’ implant

ELON Musk’s brain-chip startup Neuralink said on Tuesday (Sep 17) that its experimental implant aimed at restoring vision received the US Food and Drug Administration’s (FDA) “breakthrough device” des...

The patient, who is living with amyotrophic lateral sclerosis (ALS), was able to make video calls, play music, stream shows, control smart home devices such as lights, shop online, and read books by using his mind to direct Alexa, according to the New York-based company.

Brain implant lets man control Amazon’s Alexa with thought

A PATIENT with a degenerative disease was able to command Amazon’s Alexa digital assistant with his mind, the company behind the technological innovation announced on Monday, letting him stream shows ...

Grail expects these cost reductions to extend its existing cash runway from the second half of 2026 into 2028.

Cancer test maker Grail cuts 350 jobs as part of restructuring programme

GRAIL said on Tuesday (Aug 13) it has cut about 350 existing jobs as the diagnostics company focuses on the development of its flagship cancer-detection test Galleri, sending its shares up more than 1...

The government hopes to have the legislation passed and the regulator in operation by the end of 2025.

New Zealand to loosen gene editing regulation, make commercialisation easier

THE New Zealand government said on Tuesday (Aug 13) that it would introduce new legislation to make it easier for companies and researchers to develop and commercialise products using gene technologie...

Neuralink is in the process of testing its device, which is intended to help people with spinal cord injuries.

Neuralink implanted second trial patient with brain chip, Elon Musk says

NEURALINK has successfully implanted in a second patient its device designed to give paralysed patients the ability to use digital devices by thinking alone, according to the startup’s owner Elon Musk...

In upcoming surgeries, Neuralink will make some changes to try to mitigate the issue of its electrode threads retracting from brain tissue, Elon Musk says.

Elon Musk’s Neuralink brain device to be implanted in second human in a week

BRAIN-COMPUTER startup Neuralink aims to implant its device into a second human patient in a week or so, founder Elon Musk said during a video update on Wednesday (Jul 10), and hopes to have devices i...

Kidneys from similarly edited pigs raised by eGenesis had successfully been transplanted into monkeys that were kept alive for an average of 176 days.

First human to receive transplanted pig kidney dies

A MAN with end-stage renal disease who earlier this year became the first human to receive a new kidney from a genetically modified pig has died, Massachusetts General Hospital in Boston said.